Prolactin Protects the Structural Integrity of Human Fetal Membranes by Downregulating Inflammation-induced Secretion of Matrix Metalloproteinases

References

• Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, Romero R, Mor G. 2004. Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol. 173:4286–96.
   PubMed Web of Science ®Google Scholar
• Ben-Jonathan N, LaPensee CR, LaPensee EW. 2008. What can we learn from rodents about prolactin in humans? Endocr Rev. 29:1–41.
   PubMed Web of Science ®Google Scholar
• Binart N. 2016. Prolactin and pregnancy in mice and humans. Ann Endocrinol (Paris). 77:126–27.
   PubMed Web of Science ®Google Scholar
• Bryant-Greenwood GD. 1998. The extracellular matrix of the human fetal membranes: structure and function. Placenta. 19:1–11.
   PubMed Web of Science ®Google Scholar
• Ender Soydinc H, Erdal Sak M, Evliyaoglu O, Siddik Evsen M, Turgut A, Özler A, Yildiz I, Gul T. 2013. Prolidase, matrix metalloproteinases 1 and 13 activity, oxidative-antioxidative status as a marker of preterm premature rupture of membranes and chorioamnionitis in maternal vaginal washing fluids. Int J Med Sci. 10:1344–51.
   PubMed Web of Science ®Google Scholar
• Flores-Espinosa P, Preciado-Martínez E, Mejía-Salvador A, Sedano-González G, Bermejo-Martínez L, Parra-Covarruvias A, Estrada-Gutiérrez G, Vega-Sánchez R, Méndez I, Quesada-Reyna B, et al. 2017. Selective immuno-modulatory effect of prolactin upon pro-inflammatory response in human fetal membranes. J Reprod Immunol. 123:58–64.
   PubMed Web of Science ®Google Scholar
• Flores-Espinosa P, Vega-Sánchez R, Mancilla-Herrera I, Bermejo-Martínez L, Preciado-Martínez E, Olmos-Ortiz A, Méndez I, Estrada-Gutiérrez G, Quesada-Reyna B, Helguera-Repetto C, et al. 2019. Prolactin selectively inhibits the LPS-induced chemokine secretion of human foetal membranes. J Matern Neonatal Med. 2019:1–7.
   Google Scholar
• Fortunato SJ, LaFleur B, Menon R. 2003. Collagenase-3 (MMP-13) in fetal membranes and amniotic fluid during pregnancy. Am J Reprod Immunol. 49:120–25.
   PubMed Web of Science ®Google Scholar
• Fortunato SJ, Menon R, Lombardi SJ. 1999. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Med. 27:362–68.
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Parry S, Urbanek M, Sammel M, Macones G, Kuivaniemi H, Romero R, Strauss JF. 2002. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem. 277:6296–302.
   PubMed Web of Science ®Google Scholar
• Garcia-Lopez G, Vadillo-Ortega F, Merchant-Larios H, Maida-Claros R, Osorio M, Soriano-Becerril D, Flores-Herrera H, Beltran-Montoya J, Garfias-Becerra Y, Zaga-Clavellina V. 2007. Evidence of in vitro differential secretion of 72 and 92 kDa type IV collagenases after selective exposure to lipopolysaccharide in human fetal membranes. Mol Hum Reprod. 13:409–18.
   PubMed Web of Science ®Google Scholar
• Gilman-Sachs A, Dambaeva S, Salazar Garcia MD, Hussein Y, Kwak-Kim J, Beaman K. 2018. Inflammation induced preterm labor and birth. J Reprod Immunol. 129:53–58.
   PubMed Web of Science ®Google Scholar
• Hosny AE-DMS, Fakhry MN, El-khayat W, Kashef MT. 2019. Risk factors associated with preterm labor, with special emphasis on preterm premature rupture of membranes and severe preterm labor. J Chin Med Assoc. 83:280–87.
   Web of Science ®Google Scholar
• Kletzky OA, Rossman F, Bertolli SI, Platt LD, Mishell DR. 1985. Dynamics of human chorionic gonadotropin, prolactin, and growth hormone in serum and amniotic fluid throughout normal human pregnancy. Am J Obstet Gynecol. 151:878–84.
   PubMed Web of Science ®Google Scholar
• Kubota T, Nagae M, Yaoi Y, Kumasaka T, Saito M. 1986. Prolactin-releasing system in maternal, fetal and amniotic compartments during labor. Obstet Gynecol. 68:80–85.
   PubMed Web of Science ®Google Scholar
• Malak TM, Bell SC. 1994. Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site. BJOG Int J Obstet Gynaecol. 101:375–86.
   Google Scholar
• Maymon E, Romero R, Pacora P, Gervasi MT, Bianco K, Ghezzi F, Yoon BH. 2000. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. Am J Obstet Gynecol. 183:914–20.
   PubMed Web of Science ®Google Scholar
• McLaren J, Malak TM, Bell SC. 1999. Structural characteristics of term human fetal membranes prior to labour: identification of an area of altered morphology overlying the cervix. Hum Reprod. 14:237–41.
   PubMed Web of Science ®Google Scholar
• Menon R, Bonney EA, Condon J, Mesiano S, Taylor RN. 2016. Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition. Hum Reprod. 22:535–60.
   Web of Science ®Google Scholar
• Menon R, Richardson LS. 2017. Preterm prelabor rupture of the membranes: a disease of the fetal membranes. Semin Perinatol. 41:409–19.
   PubMed Web of Science ®Google Scholar
• Menon R, Richardson LS, Lappas M. 2019. Fetal membrane architecture, aging and inflammation in pregnancy and parturition. Placenta. 79:40–45.
   PubMed Web of Science ®Google Scholar
• Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ. 2006. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta. 27:1037–51.
   PubMed Web of Science ®Google Scholar
• Motedayyen H, Fathi F, Fasihi-Ramandi M, Ali Taheri R. 2018. The effect of lipopolysaccharide on anti-inflammatory and pro-inflammatory cytokines production of human amniotic epithelial cells. Reprod Biol. 18:404–09.
   PubMed Web of Science ®Google Scholar
• Myntti T, Rahkonen L, Nupponen I, Pätäri-Sampo A, Tikkanen M, Sorsa T, Juhila J, Andersson S, Paavonen J, Stefanovic V. 2017. Amniotic fluid infection in preterm pregnancies with intact membranes. Dis Markers. 2017:1–9.
   Web of Science ®Google Scholar
• Núñez-Sánchez E, Flores-Espinosa MDP, Mancilla-Herrera I, González L, Cisneros J, Olmos-Ortiz A, Quesada-Reyna B, Granados-Cepeda M, Zaga-Clavellina V. 2021. Prolactin modifies the in vitro LPS-induced chemotactic capabilities in human fetal membranes at the term of gestation. Am J Reprod Immunol. 4:e13413.
   Google Scholar
• Oger S, Méhats C, Dallot E, Cabrol D, Leroy MJ. 2005. Evidence for a Role of Phosphodiesterase 4 in Lipopolysaccharide-Stimulated Prostaglandin E 2 Production and Matrix Metalloproteinase-9 Activity in Human Amniochorionic Membranes . J Immunol. 174:8082–8089.
   PubMed Web of Science ®Google Scholar
• Olmos-Ortiz A, Déciga-García M, Preciado-Martínez E, Bermejo-Martínez L, Flores-Espinosa P, Mancilla-Herrera I, Irles C, Helguera-Repetto AC, Quesada-Reyna B, Goffin V, et al. 2019. Prolactin decreases LPS-induced inflammatory cytokines by inhibiting TLR-4/NFκB signaling in the human placenta. Mol Hum Reprod. 25:660–67.
   PubMed Web of Science ®Google Scholar
• Pereza N, Pleša I, Peterlin A, Ž J, Tul N, Kapović M, Ostojić S, Peterlin B. 2014. Functional polymorphisms of matrix metalloproteinases 1 and 9 genes in women with spontaneous preterm birth. Dis Markers. 2014:1–7.
   Web of Science ®Google Scholar
• Richardson LS, Vargas G, Brown T, Ochoa L, Sheller-Miller S, Saade GR, Taylor RN, Menon R. 2017. Discovery and characterization of human amniochorionic membrane microfractures. Am J Pathol. 187:2821–30.
   PubMed Web of Science ®Google Scholar
• Riley SC, Leask R, Denison FC, Wisely K, Calder AA, Howe DC. 1999. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition. J Endocrinol. 162:351–59.
   PubMed Web of Science ®Google Scholar
• Romero R, Dey SK, Fisher SJ. 2014. Preterm labor: one syndrome, many causes. Science. 345:760–65.
   PubMed Web of Science ®Google Scholar
• Soares MJ, Konno T, Alam SMK. 2007. The prolactin family: effectors of pregnancy-dependent adaptations. Trends Endocrinol Metab. 18:114–21.
   PubMed Web of Science ®Google Scholar
• Strauss JF. 2013. Extracellular matrix dynamics and fetal membrane rupture. Reprod Sci. 20:140–53.
   PubMed Web of Science ®Google Scholar
• Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno AS, Seliger G. 2018. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 46:465–88.
   PubMed Web of Science ®Google Scholar
• Thiex NW, Chames MC, Loch-Caruso RK. 2009. Tissue-specific cytokine release from human extra-placental membranes stimulated by lipopolysaccharide in a two-compartment tissue culture system. Reprod Biol Endocrinol. 7:117.
   PubMed Web of Science ®Google Scholar
• Vadillo-Ortega F, Sadowsky DW, Haluska GJ, Hernandez-Guerrero C, Guevara-Silva R, Gravett MG, Novy MJ. 2002. Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1β infusion in pregnant rhesus monkeys. Am J Obstet Gynecol. 186:128–38.
   PubMed Web of Science ®Google Scholar
• Vincent ZL, Mitchell MD, Ponnampalam AP. 2015. Regulation of TIMP-1 in human placenta and fetal membranes by lipopolysaccharide and demethylating agent 5-aza-2ʹ-deoxycytidine. Reprod Biol Endocrinol. 13:136.
   PubMed Web of Science ®Google Scholar
• Vu TD, Feng Y, Placido J, Reznik SE. 2008. Placental matrix metalloproteinase-1 expression is increased in labor. Reprod Sci. 15:420–24.
   PubMed Web of Science ®Google Scholar
• Wang YW, Wang WS, Wang LY, Bao YR, Lu JW, Lu Y, Zhang CY, Li WJ, Sun K, Ying H. 2019. Extracellular matrix remodeling effects of serum amyloid A1 in the human amnion: implications for fetal membrane rupture. Am J Reprod Immunol. 81:e13073.
   PubMed Web of Science ®Google Scholar
• Xu P, Alfaidy N, Challis JRG. 2002. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab. 87:1353–61.
   PubMed Web of Science ®Google Scholar
• Yonemoto H, Young CB, Ross JT, Guilbert LL, Fairclough RJ, Olson DM. 2006. Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor. Placenta. 27:669–77.
   PubMed Web of Science ®Google Scholar
• Zaga V, Estrada-Gutierrez G, Beltran-Montoya J, Maida-Claros R, Lopez-Vancell R, Vadillo-Ortega F. 2004. Secretions of interleukin-1β and tumor necrosis factor α by whole fetal membranes depend on initial interactions of amnion or choriodecidua with lipopolysaccharides or group B streptococci1. Biol Reprod. 71:1296–302.
   PubMed Web of Science ®Google Scholar
• Zaga-Clavellina V, Garcia-Lopez G, Flores-Pliego A, Merchant-Larios H, Vadillo-Ortega F. 2011. In vitro secretion and activity profiles of matrix metalloproteinases, MMP-9 and MMP-2, in human term extra-placental membranes after exposure to Escherichia coli. Reprod Biol Endocrinol. 9:13.
   PubMed Web of Science ®Google Scholar
• Zaga-Clavellina V, Merchant-Larios H, García-López G, Maida-Claros R, Vadillo-Oretega F. 2006a. Differential Secretion of matrix metalloproteinase-2 and −9 after selective infection with group B streptococci in human fetal membranes. J Soc Gynecol Investig. 13:271–79.
   PubMedGoogle Scholar
• Zaga-Clavellina V, Merchant-Larios H, García-López G, Maida-Claros R, Vadillo-Ortega F. 2006b. Differential secretion of matrix metalloproteinase-2 and −9 after selective infection with group B streptococci in human fetal membranes. J Soc Gynecol Investig. 13:271–79.
   PubMedGoogle Scholar